Hypouricaemic effect of polyethyleneglycol modified urate oxidase.
D000368:Aged; D000481:Allantoin / Q000378:metabolism; D000493:Allopurinol / Q000627:therapeutic use; D002175:Candida / Q000201:enzymology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D014503:Urate Oxidase / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood* / Q000652:urine
D014527:Uric Acid; D000481:Allantoin; D011092:Polyethylene Glycols; D000493:Allopurinol; D014503:Urate Oxidase; C031545:Pegloticase